DeepNoid

DeepNoid CROIC

The Cash Return on Invested Capital (CROIC) of DeepNoid (315640.KQ) as of Nov 3, 2026 is -20.60 %. In the previous year, Cash Return on Invested Capital (CROIC) was -90.05 % — a change of -77.13% (higher).

CROIC

-20.60 %

YoY

-77.13%

Last updated:

Cash Return on Invested Capital (CROIC) of DeepNoid is 2025 -20.60 % . Cash Return on Invested Capital (CROIC) of DeepNoid was 2024 -90.05 % . It decreases by -77.13% higher compared to the previous year.

The DeepNoid CROIC history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CROIC
Date
CROIC
Jan 1, 2018
67.08 KRW
Jan 1, 2019
28.29 KRW
Jan 1, 2020
-284.63 KRW
Jan 1, 2021
-40.20 KRW
Jan 1, 2022
-39.51 KRW
Jan 1, 2023
-20.08 KRW
Jan 1, 2024
-90.05 KRW
Jan 1, 2025
-20.60 KRW
The DeepNoid CROIC history
YEARCROICYoY
-20.60 %-77.13%
-90.05 %+348.39%
-20.08 %-49.16%
-39.51 %-1.73%
-40.20 %-85.88%
-284.63 %-1,106.23%
28.29 %-57.83%
67.08 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

DeepNoid Stock analysis

What does DeepNoid do? DeepNoid Inc generates revenue through its AI medical imaging analytics platform, offering DEEP:AI, DEEP:PHI, DEEP:STORE, and DEEP:PACS as core products. These solutions support medical research and clinical decision-making, targeting healthcare providers and institutions seeking accurate diagnostic tools. The company's ecosystem integrates research and clinical applications, creating a continuous value loop for users. Its all-in-one platform is designed for efficiency in both research and real-world clinical settings. The firm's product suite serves healthcare organizations requiring advanced imaging analytics, with DEEP:AI focusing on research and DEEP:PHI, DEEP:STORE, and DEEP:PACS supporting clinical workflows. These products are sold to hospitals and medical institutions that prioritize AI-driven diagnostic accuracy and operational efficiency. The integrated platform model ensures ongoing engagement with clients through continuous updates and ecosystem expansion. DeepNoid's business model revolves around delivering a unified medical AI platform that bridges research and clinical practice. By providing comprehensive solutions under one ecosystem, the company secures recurring revenue streams from healthcare providers who adopt its suite of products. The focus on seamless integration and continuous value creation drives client retention and expansion within the healthcare sector. DeepNoid is one of the most popular companies on Eulerpool.

Frequently Asked Questions about DeepNoid stock

Cash Return on Invested Capital (CROIC) of DeepNoid is -20.60 % in 2025.

Cash Return on Invested Capital (CROIC) of DeepNoid changed from -90.05 % to -20.60 %, representing a -77.13% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Cash Return on Invested Capital (CROIC) DeepNoid since 2006 – with annual values, charts, and detailed analysis.

CROIC measures the cash return generated on invested capital. Unlike ROIC, it uses free cash flow instead of accounting earnings, providing a purer profitability measure.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Return on Invested Capital (CROIC)'s DeepNoid with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Return on Invested Capital (CROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Return on Invested Capital (CROIC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — DeepNoid

All Key Metrics — DeepNoid